Literature DB >> 10846570

Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas.

K Taniyama1, N Sasaki, S Wada, M Sasaki, N Miyoshi, H Nakai, S Kodama, H Nakatsuka, E Tahara.   

Abstract

Twenty-eight moderately differentiated adenocarcinomas invading beyond the muscularis propria of the colorectum were subclassified as 13 moderate- and 15 poor-subtype tumors based on the histology at the deeply infiltrating sites. Moderately differentiated cancer cells were correlated with liver metastasis and p53 immunoreactivity. Poorly differentiated cancer cells were correlated with lymph node metastases but not to p53 immunoreactivity. The proliferative cell nuclear antigen (PCNA) labeling index (LI), Ki-67 LI and agyrophilic nuclear organizer regions (AgNOR) values determined for the poorly differentiated cancer cells in the poor-subtype tumors were significantly lower than those of moderately differentiated cancer cells in the moderate-subtype tumors. In cells from tumors classified as poor-subtype, poor differentiation was associated with decreased PCNA LI levels, but with unchanged Ki-67 LI and AgNOR values. These results indicate that colorectal adenocarcinoma cells that are histologically subclassified as moderately differentiated have different proliferative and metastatic activities from cancer cells that are poorly differentiated. Moderately differentiated cancer cells are associated with hematogenous metastasis to liver and high proliferative activity, and loss of tubular formation of cancer cells may be fundamentally related to lymph node metastasis and infiltrative growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10846570     DOI: 10.1111/j.1440-1827.1996.tb03598.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters.

Authors:  R Palmqvist; J N Rutegârd; B Bozoky; G Landberg; R Stenling
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.

Authors:  Attalla F El-kott; Mahmoud A El-baz; Alaa A Mokhtar
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.

Authors:  R Palmqvist; A Oberg; C Bergström; J N Rutegård; B Zackrisson; R Stenling
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

4.  Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.

Authors:  Anna Gasinska; Jan Skolyszewski; Tadeusz Popiela; Piotr Richter; Zbigniew Darasz; Krystyna Nowak; Joanna Niemiec; Beata Biesaga; Agnieszka Adamczyk; Krzysztof Bucki; Krzysztof Malecki; Marian Reinfuss; Teresa Kowalska
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

5.  Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.

Authors:  R Palmqvist; P Sellberg; A Oberg; B Tavelin; J N Rutegård; R Stenling
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.